Related Experiment Video
Updated: Jul 20, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Prevention of perinatal transmission of hepatitis B virus carrier state
Insights
Passive and active immunization effectively protected most infants from hepatitis B virus (HBV) carrier status. This strategy is crucial for preventing vertical HBV transmission and future liver disease.
Area of Science:
- Hepatology
- Immunology
- Pediatrics
Background:
- Hepatitis B virus (HBV) poses a significant risk for vertical transmission from carrier mothers to newborns.
- Establishing the HBV carrier state in infants can lead to chronic liver disease.
Purpose of the Study:
- To evaluate the efficacy of passive and active immunization in preventing vertical HBV transmission.
- To assess the long-term protection against HBV carrier state in infants born to HBV-positive mothers.
Main Methods:
- A cohort of 407 infants born to hepatitis B antigen-positive mothers received hepatitis B immunoglobulin and hepatitis B vaccine.
- Infants were monitored for 12 months or longer to determine HBV carrier status.
- Seroconversion of anti-HBc was assessed in protected infants.
Main Results:
- 396 out of 407 infants (97.3%) were protected from becoming HBV carriers.
- 11 infants developed HBV carrier status (4 before, 7 after immunoprophylaxis completion).
- 26.8% of protected infants showed anti-HBc seroconversion.
Conclusions:
- Combined passive and active immunization is highly effective in preventing vertical HBV transmission.
- This immunoprophylaxis strategy significantly reduces the risk of infants becoming HBV carriers.
- Nationwide implementation of these measures is expected to lead to the elimination of HBV-related liver diseases.
Abstract:
By means of passive and active immunization with hepatitis B immunoglobulin and hepatitis B vaccine, 396 of 407 babies born to hepatitis B antigen-positive carrier mothers, were protected from establishing the hepatitis B virus (HBV) carrier state during a follow-up period of 12 months or longer. Four infants developed the HBV carrier state before the completion of the immunoprophylaxis schedule, and another seven developed the state after the completion of the schedule. Seroconversion of anti-HBc was observed in 26.8% of the successfully protected infants. In Japan a nationwide program to prevent the vertical transmission of HBV with these procedures was established in 1986, and so liver diseases due to HBV are expected to be eliminated in the near future.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
04:11Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Related Concept Videos
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Hepatitis
Viral Hepatitis I: Introduction